Armed with Donation from Trial Participant’s Family, Cognition Initiates Expanded Access Program for Experimental DLB Drug
Armed With Donation From Trial Participant’s Family, Cognition (Nasdaq: CGTX) Initiates Expanded Access Program For Experimental DLB Drug
Benzinga
By Meg Flippin
June 11, 2025